Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus.

Australia Consensus Delphi Technique Female Humans Male Neoplasm Staging Pancreatic Neoplasms / diagnosis Quality Indicators, Health Care Quality of Life

Journal

HPB : the official journal of the International Hepato Pancreato Biliary Association
ISSN: 1477-2574
Titre abrégé: HPB (Oxford)
Pays: England
ID NLM: 100900921

Informations de publication

Date de publication:
04 2019
Historique:
received: 15 03 2018
revised: 02 08 2018
accepted: 31 08 2018
pubmed: 15 10 2018
medline: 4 4 2020
entrez: 15 10 2018
Statut: ppublish

Résumé

Best practise care optimises survival and quality of life in patients with pancreatic cancer (PC), but there is evidence of variability in management and suboptimal care for some patients. Monitoring practise is necessary to underpin improvement initiatives. We aimed to develop a core set of quality indicators that measure quality of care across the disease trajectory. A modified, three-round Delphi survey was performed among experts with wide experience in PC care across three states in Australia. A total of 107 potential quality indicators were identified from the literature and divided into five areas: diagnosis and staging, surgery, other treatment, patient management and outcomes. A further six indicators were added by the panel, increasing potential quality indicators to 113. Rated on a scale of 1-9, indicators with high median importance and feasibility (score 7-9) and low disagreement (<1) were considered in the candidate set. From 113 potential quality indicators, 34 indicators met the inclusion criteria and 27 (7 diagnosis and staging, 5 surgical, 4 other treatment, 5 patient management, 6 outcome) were included in the final set. The developed indicator set can be applied as a tool for internal quality improvement, comparative quality reporting, public reporting and research in PC care.

Sections du résumé

BACKGROUND
Best practise care optimises survival and quality of life in patients with pancreatic cancer (PC), but there is evidence of variability in management and suboptimal care for some patients. Monitoring practise is necessary to underpin improvement initiatives. We aimed to develop a core set of quality indicators that measure quality of care across the disease trajectory.
METHODS
A modified, three-round Delphi survey was performed among experts with wide experience in PC care across three states in Australia. A total of 107 potential quality indicators were identified from the literature and divided into five areas: diagnosis and staging, surgery, other treatment, patient management and outcomes. A further six indicators were added by the panel, increasing potential quality indicators to 113. Rated on a scale of 1-9, indicators with high median importance and feasibility (score 7-9) and low disagreement (<1) were considered in the candidate set.
RESULTS
From 113 potential quality indicators, 34 indicators met the inclusion criteria and 27 (7 diagnosis and staging, 5 surgical, 4 other treatment, 5 patient management, 6 outcome) were included in the final set.
CONCLUSIONS
The developed indicator set can be applied as a tool for internal quality improvement, comparative quality reporting, public reporting and research in PC care.

Identifiants

DOI: 10.1016/j.hpb.2018.08.016 PMID: 30316625
pubmed: 30316625
pii: S1365-182X(18)33948-0
doi: 10.1016/j.hpb.2018.08.016
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

444-455

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Ashika D Maharaj (AD)

Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.

Liane Ioannou (L)

Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.

Daniel Croagh (D)

Monash University, Melbourne, Victoria, Australia; Monash Health, Clayton, Victoria, Australia; Epworth Healthcare, Richmond, Australia.

John Zalcberg (J)

Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia.

Rachel E Neale (RE)

QIMR Berghofer Medical Research Institute, Herston, Australia.

David Goldstein (D)

Prince of Wales Clinical School, UNSW Medicine, NSW, Australia.

Neil Merrett (N)

School of Medicine, Western Sydney University, NSW, Australia.

James G Kench (JG)

Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Central Clinical School, University of Sydney, NSW, Australia.

Kate White (K)

Sydney Nursing School, University of Sydney, Australia.

Charles H C Pilgrim (CHC)

Alfred Health, Melbourne, Victoria, Australia; Cabrini, Malvern, Victoria, Australia; Peninsula Health, Frankston, Victoria, Australia; Peninsula Private Hospital, Frankston, Victoria, Australia.

Lorraine Chantrill (L)

Kinghorn Cancer Centre, St Vincent's Hospital, NSW, Australia; Garvan Institute of Medical Research and University of New South Wales, NSW, Australia.

Peter Cosman (P)

School of Medicine, Faculty of Science, Medicine & Health, University of Wollongong, NSW, Australia.

Andrew Kneebone (A)

Northern Clinical School, University of Sydney, Australia.

Lara Lipton (L)

Cabrini, Malvern, Victoria, Australia; Royal Melbourne Hospital, Parkville, Victoria, Australia; Western Health, Sunshine, Victoria, Australia.

Mehrdad Nikfarjam (M)

Melbourne University, Parkville, Victoria, Australia; Austin Health, Heidelberg, Australia.

Jennifer Philip (J)

Melbourne University, Parkville, Victoria, Australia.

Charbel Sandroussi (C)

Central Clinical School, University of Sydney, NSW, Australia.

Peter Tagkalidis (P)

Alfred Health, Melbourne, Victoria, Australia; Royal Melbourne Hospital, Parkville, Victoria, Australia.

Richard Chye (R)

St Vincent's Private Hospital, Darlinghurst, NSW, Australia; Faculty of Health, University of Technology, NSW, Australia.

Koroush S Haghighi (KS)

Prince of Wales Clinical School, UNSW Medicine, NSW, Australia; Kinghorn Cancer Centre, St Vincent's Hospital, NSW, Australia.

Jaswinder Samra (J)

Department of Upper GI Surgery, Royal North Shore Hospital, NSW, Australia; Macquarie University Hospital, Macquarie University, Australia.

Sue M Evans (SM)

Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, Australia. Electronic address: sue.evans@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Monitoring quality of care for patients with...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Monitoring quality of care for patients with...
questionsmedicales.fr › Sciences de l'information › Analyse des systèmes › Méthode Delphi › Monitoring quality of care for patients with...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Monitoring quality of care for patients with...
questionsmedicales.fr › Diagnostic › Pronostic › Stadification tumorale › Monitoring quality of care for patients with...
questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs du pancréas › Monitoring quality of care for patients with...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Indicateurs qualité santé › Monitoring quality of care for patients with...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Monitoring quality of care for patients with...